Pages that link to "Q28204942"

The following pages link to Inhibition of food intake in obese subjects by peptide YY3-36 (Q28204942):

Displaying 50 items.

• Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index (Q21144740) (← links)
• The role of proopiomelanocortin (POMC) neurones in feeding behaviour (Q21245071) (← links)
• Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women (Q21245644) (← links)
• The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with [...] (Q21284847) (← links)
• The gut hormones in appetite regulation (Q21296779) (← links)
• Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System (Q24601868) (← links)
• Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing (Q24604695) (← links)
• The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control (Q24629879) (← links)
• Endocrine disrupters as obesogens (Q24647272) (← links)
• Neuropeptide Y Y2 receptor in health and disease (Q24648453) (← links)
• Gastrointestinal hormones regulating appetite (Q24669951) (← links)
• Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss (Q26741066) (← links)
• Metabolic signals in sleep regulation: recent insights (Q26770483) (← links)
• Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review (Q26780440) (← links)
• The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD) (Q26782555) (← links)
• The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones (Q26783535) (← links)
• Diet in irritable bowel syndrome (Q26824367) (← links)
• Obesity pharmacotherapy: current perspectives and future directions (Q26828559) (← links)
• Development of minimally invasive techniques for management of medically-complicated obesity (Q26851369) (← links)
• Models and strategies in the development of antiobesity drugs (Q27002468) (← links)
• Gut Microbiota: A Contributing Factor to Obesity (Q28066301) (← links)
• Exercise, Appetite and Weight Control: Are There Differences between Men and Women? (Q28076371) (← links)
• (Q28160748) (redirect page) (← links)
• Obesity wars: molecular progress confronts an expanding epidemic (Q28240764) (← links)
• Characterization of brainstem peptide YY (PYY) neurons (Q28257925) (← links)
• Gut hormones and the regulation of energy homeostasis (Q28278826) (← links)
• Effect of shortened sleep on energy expenditure, core body temperature, and appetite: a human randomised crossover trial (Q28365180) (← links)
• Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies (Q28541879) (← links)
• Causality of small and large intestinal microbiota in weight regulation and insulin resistance (Q28828501) (← links)
• Melanocortin neurons: Multiple routes to regulation of metabolism (Q30234481) (← links)
• Peptide YY, appetite and food intake. (Q30350893) (← links)
• Antiobesity pharmacotherapy: new drugs and emerging targets (Q30354242) (← links)
• The future role of gut hormones in the treatment of obesity (Q30357431) (← links)
• Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-cell peptides: protocol for a cross-sectional study. (Q30385657) (← links)
• The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity (Q30388925) (← links)
• Changes in neurohormonal gut peptides following bariatric surgery (Q30391329) (← links)
• The pharmacological treatment and management of obesity (Q30399340) (← links)
• Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity (Q30399390) (← links)
• Tackling obesity: new therapeutic agents for assisted weight loss. (Q30401145) (← links)
• Regulation of appetite to treat obesity (Q30403705) (← links)
• New advances in models and strategies for developing anti-obesity drugs (Q30429816) (← links)
• Habituation as a determinant of human food intake (Q30488736) (← links)
• A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior (Q30809802) (← links)
• Feeding frequency and appetite in lean and obese prepubertal children (Q30828866) (← links)
• Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion (Q31115560) (← links)
• The GRAFS classification system of G-protein coupled receptors in comparative perspective (Q31165781) (← links)
• Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice (Q33521218) (← links)
• Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome (Q33587895) (← links)
• Ghrelin and peptide YY in postpartum lactating and nonlactating women (Q33592340) (← links)
• Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects (Q33592515) (← links)